Cepheid
Cepheid, Oxford Nanopore to Broaden Use Case for Nanopore Sequencing in Infectious Disease Testing
Premium
The firms are developing a workflow that will include Cepheid's sample and library preparation, nanopore sequencing, and automated data analysis.
Top Five Articles on 360Dx Last Week: Roche's HPV Self-Collection Device; More
Last week, readers were most interested in a story about Roche ramping up the commercialization of its sample self-collection devices for HPV.
Oxford Nanopore Technologies, Cepheid Partner for Automated Pathogen Sequencing
The two firms aim to develop an end-to-end solution to simplify the nanopore sequencing workflow and eventually enable expanded clinical use.
Top Five Articles on 360Dx Last Week: Cuts in US Funding for TB; FDA OKs Visby Medical STD Test; More
Last week, readers were most interested in a story about the potentially devastating effects that cuts in US funding for tuberculosis may have.
Top Five Articles on 360Dx Last Week: Cepheid Layoffs; Federal Spending Squeeze at Quanterix; More
Last week, readers were most interested in a story about layoffs at Cepheid that will take effect in May.